MX9705312A - Derivados de benzazepina, biciclicos como antagonistas de la vasopresina. - Google Patents
Derivados de benzazepina, biciclicos como antagonistas de la vasopresina.Info
- Publication number
- MX9705312A MX9705312A MX9705312A MX9705312A MX9705312A MX 9705312 A MX9705312 A MX 9705312A MX 9705312 A MX9705312 A MX 9705312A MX 9705312 A MX9705312 A MX 9705312A MX 9705312 A MX9705312 A MX 9705312A
- Authority
- MX
- Mexico
- Prior art keywords
- vasopressin antagonists
- conditions
- benzazepine derivatives
- bicyclic
- vasopressin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Esta invencion se refiere a nuevos antagonistas de vasopresina no peptidicos, bicíclicos de la formula (I), los cuales se utilizan en tratamiento de condiciones donde se desean niveles de vasopresina disminuidos, tal como en falla del corazon congestiva, en condiciones de enfermedad con reabsorcion de agua renal, en exceso y en condiciones con resistencia vascular incrementada y vasoconstruccion coronaria.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/373,839 US5696112A (en) | 1995-01-17 | 1995-01-17 | Fused heterocyclic azepines as vasopressin antagonists |
PCT/US1996/001096 WO1996022294A1 (en) | 1995-01-17 | 1996-01-16 | Bicyclic benzazepine derivatives as vasopressin antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9705312A true MX9705312A (es) | 1997-10-31 |
Family
ID=23474102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9705312A MX9705312A (es) | 1995-01-17 | 1996-01-16 | Derivados de benzazepina, biciclicos como antagonistas de la vasopresina. |
Country Status (23)
Country | Link |
---|---|
US (2) | US5696112A (es) |
EP (1) | EP0811008B1 (es) |
JP (1) | JPH10512572A (es) |
KR (1) | KR19980703098A (es) |
CN (1) | CN1177356A (es) |
AR (1) | AR010195A1 (es) |
AT (1) | ATE251166T1 (es) |
AU (1) | AU716008B2 (es) |
BR (1) | BR9607153A (es) |
CA (1) | CA2210571A1 (es) |
CZ (1) | CZ224697A3 (es) |
DE (1) | DE69630209T2 (es) |
DK (1) | DK0811008T3 (es) |
EA (1) | EA001427B1 (es) |
ES (1) | ES2207672T3 (es) |
HU (1) | HUP9800466A3 (es) |
IL (1) | IL116776A (es) |
MX (1) | MX9705312A (es) |
NZ (1) | NZ302119A (es) |
PT (1) | PT811008E (es) |
TW (1) | TW342385B (es) |
WO (1) | WO1996022294A1 (es) |
ZA (1) | ZA96298B (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997017349A1 (fr) * | 1995-11-09 | 1997-05-15 | Japan Tobacco Inc. | Derives heterocycliques fusionnes pentagonaux d'azepine et leur emploi pharmaceutique |
US6297234B1 (en) | 1999-02-04 | 2001-10-02 | American Home Products Corporation | Arylthiophene vasopressin agonists |
US6235900B1 (en) | 1999-02-04 | 2001-05-22 | American Home Products Corporation | Tricyclic pyridine N-oxides vasopressin agonists |
US6437006B1 (en) | 1999-09-27 | 2002-08-20 | American Cyanamid Company | Pharmaceutical carrier formulation |
US6900200B2 (en) | 2001-04-12 | 2005-05-31 | Wyeth | Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
US6977254B2 (en) * | 2001-04-12 | 2005-12-20 | Wyeth | Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
US7326700B2 (en) * | 2001-04-12 | 2008-02-05 | Wyeth | Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
US7022699B2 (en) | 2001-04-12 | 2006-04-04 | Wyeth | Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
CA2443870A1 (en) | 2001-04-12 | 2002-10-24 | Wyeth | Cyclohexylphenyl vasopressin agonists |
JP2004530668A (ja) | 2001-04-12 | 2004-10-07 | ワイス | バソプレッシンアゴニストとしてのn−ビフェニルカルボニル−およびn−フェニルピリジルカルボニル置換二および三環アゼピンおよびジアゼピン |
US7202239B2 (en) * | 2001-04-12 | 2007-04-10 | Wyeth | Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists |
US7109193B2 (en) | 2001-04-12 | 2006-09-19 | Wyeth | Tricyclic diazepines tocolytic oxytocin receptor antagonists |
US7064120B2 (en) * | 2001-04-12 | 2006-06-20 | Wyeth | Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
EP1632494A1 (en) * | 2004-08-24 | 2006-03-08 | Ferring B.V. | Vasopressin v1a antagonists |
CN101370796B (zh) * | 2006-01-18 | 2012-10-10 | 霍夫曼-拉罗奇有限公司 | 作为11β-HSD1抑制剂的噻唑类 |
US8193372B2 (en) * | 2009-03-04 | 2012-06-05 | Idenix Pharmaceuticals, Inc. | Phosphothiophene and phosphothiazole HCV polymerase inhibitors |
WO2010116176A1 (en) | 2009-04-09 | 2010-10-14 | Astrazeneca Ab | Pyrazolo [4, 5-e] pyrimidine derivative and its use to treat diabetes and obesity |
US10626126B2 (en) | 2016-04-08 | 2020-04-21 | Pulmocide Limited | Compounds |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA821020B (en) * | 1981-02-18 | 1983-10-26 | Thomae Gmbh Dr K | Azepine derivatives, process for their preparation and pharmaceutical compositions thereof |
US4766108A (en) * | 1986-12-04 | 1988-08-23 | Smith Kline Beckman Corporation | Tyr-Arg-vasopressin antagonists |
US5055448A (en) * | 1987-06-25 | 1991-10-08 | Medical College Of Ohio | Linear derivatives of arginine vasopressin antagonists |
DK0382185T3 (da) * | 1989-02-10 | 1994-07-04 | Otsuka Pharma Co Ltd | Carbostyrilderivater |
DE122009000062I2 (de) * | 1989-10-20 | 2011-01-13 | Otsuka Pharma Co Ltd | Benzoheterozyklische verbindungen |
US5258510A (en) * | 1989-10-20 | 1993-11-02 | Otsuka Pharma Co Ltd | Benzoheterocyclic compounds |
US5070187A (en) * | 1989-11-03 | 1991-12-03 | Trustees Of Boston University | Pharmacologically effective antagonists of arginine-vasopressin |
TW199153B (es) * | 1990-08-07 | 1993-02-01 | Dtsuka Seiyaku Kk | |
CA2066104C (en) * | 1991-04-19 | 2003-05-27 | Hidenori Ogawa | Benzazepine derivatives as vasopressin antagonists |
EP0533240A3 (en) * | 1991-09-16 | 1993-09-29 | Merck & Co. Inc. | Substituted amine derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
DE69223573D1 (de) * | 1991-09-16 | 1998-01-29 | Merck & Co Inc | Hydantoin und Succinimid-substituierte Spiroindanylcamphorsulfonyl als Oxytocin-Antagonisten |
US5204349A (en) * | 1991-09-16 | 1993-04-20 | Merck & Co., Inc. | Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists |
EP0533242A3 (en) * | 1991-09-16 | 1993-09-15 | Merck & Co. Inc. | Substituted derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
WO1994004525A1 (en) * | 1992-08-20 | 1994-03-03 | Otsuka Pharmaceutical Company, Limited | Benzoheterocyclic compounds as oxytocin and vasopressin antagonists |
TW270927B (es) * | 1992-10-16 | 1996-02-21 | Otsuka Pharma Co Ltd | |
WO1994012476A1 (en) * | 1992-11-25 | 1994-06-09 | Yamanouchi Pharmaceutical Co., Ltd. | Benzanilide derivative |
AU5692094A (en) * | 1992-12-21 | 1994-07-19 | Yamanouchi Pharmaceutical Co., Ltd. | Novel n-(pyridylcarbonyl)benzazepine derivative and intermediate therefor |
AU6219994A (en) * | 1993-03-11 | 1994-09-26 | Yamanouchi Pharmaceutical Co., Ltd. | Compound with vasopressin antagonism |
GB9307527D0 (en) * | 1993-04-13 | 1993-06-02 | Fujisawa Pharmaceutical Co | New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same |
-
1995
- 1995-01-17 US US08/373,839 patent/US5696112A/en not_active Expired - Lifetime
- 1995-06-02 US US08/460,418 patent/US5654297A/en not_active Expired - Lifetime
-
1996
- 1996-01-15 ZA ZA96298A patent/ZA96298B/xx unknown
- 1996-01-15 AR ARP960101028A patent/AR010195A1/es not_active Application Discontinuation
- 1996-01-16 DK DK96903711T patent/DK0811008T3/da active
- 1996-01-16 MX MX9705312A patent/MX9705312A/es not_active IP Right Cessation
- 1996-01-16 ES ES96903711T patent/ES2207672T3/es not_active Expired - Lifetime
- 1996-01-16 KR KR1019970704946A patent/KR19980703098A/ko not_active Application Discontinuation
- 1996-01-16 EA EA199700115A patent/EA001427B1/ru not_active IP Right Cessation
- 1996-01-16 CA CA002210571A patent/CA2210571A1/en not_active Abandoned
- 1996-01-16 AU AU47706/96A patent/AU716008B2/en not_active Ceased
- 1996-01-16 EP EP96903711A patent/EP0811008B1/en not_active Expired - Lifetime
- 1996-01-16 NZ NZ302119A patent/NZ302119A/en unknown
- 1996-01-16 AT AT96903711T patent/ATE251166T1/de not_active IP Right Cessation
- 1996-01-16 HU HU9800466A patent/HUP9800466A3/hu unknown
- 1996-01-16 TW TW085100460A patent/TW342385B/zh active
- 1996-01-16 BR BR9607153A patent/BR9607153A/pt unknown
- 1996-01-16 DE DE69630209T patent/DE69630209T2/de not_active Expired - Fee Related
- 1996-01-16 CN CN96192356A patent/CN1177356A/zh active Pending
- 1996-01-16 PT PT96903711T patent/PT811008E/pt unknown
- 1996-01-16 CZ CZ972246A patent/CZ224697A3/cs unknown
- 1996-01-16 WO PCT/US1996/001096 patent/WO1996022294A1/en active IP Right Grant
- 1996-01-16 JP JP8522453A patent/JPH10512572A/ja not_active Ceased
- 1996-01-16 IL IL11677696A patent/IL116776A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69630209T2 (de) | 2004-08-19 |
AU4770696A (en) | 1996-08-07 |
EA001427B1 (ru) | 2001-02-26 |
HUP9800466A2 (hu) | 1998-07-28 |
EA199700115A1 (ru) | 1997-12-30 |
CA2210571A1 (en) | 1996-07-25 |
ZA96298B (en) | 1997-07-15 |
BR9607153A (pt) | 1997-11-11 |
JPH10512572A (ja) | 1998-12-02 |
CN1177356A (zh) | 1998-03-25 |
DE69630209D1 (de) | 2003-11-06 |
WO1996022294A1 (en) | 1996-07-25 |
DK0811008T3 (da) | 2004-01-26 |
ATE251166T1 (de) | 2003-10-15 |
AU716008B2 (en) | 2000-02-17 |
KR19980703098A (ko) | 1998-10-15 |
AR010195A1 (es) | 2000-06-07 |
EP0811008B1 (en) | 2003-10-01 |
IL116776A (en) | 2000-10-31 |
ES2207672T3 (es) | 2004-06-01 |
US5696112A (en) | 1997-12-09 |
TW342385B (en) | 1998-10-11 |
PT811008E (pt) | 2004-02-27 |
NZ302119A (en) | 2000-02-28 |
US5654297A (en) | 1997-08-05 |
IL116776A0 (en) | 1996-05-14 |
EP0811008A1 (en) | 1997-12-10 |
CZ224697A3 (cs) | 1998-01-14 |
HUP9800466A3 (en) | 1998-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9705312A (es) | Derivados de benzazepina, biciclicos como antagonistas de la vasopresina. | |
AU6877694A (en) | Tricyclic benzazepine vasopressin antagonists | |
WO2000043398A3 (en) | Tricyclic benzodiazepines as vasopressin receptor antagonists | |
MXPA99000214A (es) | Antagonistas de la vasopresina, a base de benzazepinas triciclicas. | |
DE69616480T2 (de) | Piperidinderivate als neurokininantagonisten | |
MX9705415A (es) | Antagonsitas de vasopresina triciclicos de benzazepina. | |
EA199700117A1 (ru) | Трициклические бензазепиновые антагонисты вазопрессина, способ их получения, фармацевтическая композиция и способ лечения млекопитающих с использованием трициклических бензазепинов | |
MY104140A (en) | Substituted pyrrole, pyrazole and triazole angiotensin ii antagonists | |
DE69410790D1 (de) | Bicyclische ansamycine und ihre verwendung als antitumormittel | |
IE902139L (en) | Imidazolyl alkenoic acids | |
CA2268327A1 (en) | 3-carboxamide derivatives of 5h-pyrrolo[2,1-c][1,4]-benzodiazepines | |
BG106423A (en) | Isomeric fused pyrrolocarbazoles and isoindolones | |
MD970227A (ro) | Dihidropirimidine şi utilizarea lor | |
MY110205A (en) | Imidazolyl-alkenoic acids. | |
CA2080705A1 (en) | Substituted pyrimidines | |
CA2062837A1 (en) | 8-substituted purines as selective adenosine receptor agents | |
CA2110806A1 (en) | 4-(1h-pyrrol-1-yl)imidazoles with angiotensin ii antagonist activity | |
CA2055637A1 (en) | Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia | |
MX9707683A (es) | Composiciones de combinacion que contienen benazepril o benazeprilat y valsartan. | |
MX9708416A (es) | Derivados de piperazino como antagonistas de neuroquininas. | |
NZ331789A (en) | Method of treating heart failure with non-peptide endothelin antagonists | |
DE69324910T2 (de) | Triazolopyrimidinderivate als angiotensin-ii rezeptor antagonisten | |
MX9307047A (es) | Compuestos de quinazolinas y bencimidazoles substituidos. | |
IL147130A0 (en) | Indoloazepines as vasopressin receptor antagonists | |
WO2006049984A3 (en) | Novel [1,4]benzodiazepines as vasopressin v2 receptor antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |